Veristat Strengthens Senior Management Team: Appoints Faith Haines Kolb as Vice President,...
SOUTHBOROUGH, MA – March 08, 2016 – Veristat, a full service Clinical Research Organization (CRO), announced today the appointment of Faith...
Veristat participates in Cycle for Survival 2016 and raises over $20,000 to fund rare...
Veristat Raises over $20,000 to Support Rare Cancer Research
On Saturday, February 27th, Team Veristat JOINED THE BATTLE with Cycle for...
Veristat Rides in Cycle for Survival 2016 Event to Raise Money to Fight Rare Cancers
Veristat Supports the Upcoming Boston Cycle for Survival Event Join Veristat in the Fight Against Rare Cancers: Donate Today!
Veristat and Cidara Therapeutics Collaborate with a Preferred Provider Agreement
Veristat to Assist Cidara with Its Trials for Novel Echinocandin Antifungal CD101
Veristat Continues Decade Long Preferred Partnership with EndoCeutics
Veristat Assists EndoCeutics with NDA Submission for Intravaginal Prasterone
Veristat Recognized as One of America’s Fast-Growing Companies on the 2015 Inc. 5000 List
Veristat announced that it has been recognized by Inc. Magazine as one of the Countries’ fastest-growing private companies.
Veristat Completes Move into New Corporate Headquarters
SOUTHBOROUGH, MA – July 13, 2015 – Veristat, a full service Clinical Research Organization (CRO), announced today that it has completed the...